Do you have lymphedema? Please respond to this anonymous on-line survey: bit.ly/3ucmzH6 It will take only 3 minutes, but your participation is extremely important! This data will help us to inform doctors, hospitals, insurers, and the government about #lymphedema

Do you have lymphedema? Please respond to this anonymous on-line survey: bit.ly/3ucmzH6 It will take only 3 minutes, but your participation is extremely important! This data will help us to inform doctors, hospitals, insurers, and the government about #lymphedema

Today, we enrolled the first subject in the HEAL trial (Human Upper Extremity Acebilustat Lymphedema Trial). The study is intended to further investigate the ability of the specific LTB4 antagonist to reverse the structural damage in human chronic #lymphedema.

Our open-label study of patients with arm lymphedema is envisioned as the next step in potential drug approval for the treatment of lymphedema. This is a very exciting day for my team and for the lymphedema community.

The current trial is the culmination of more than two decades of research in the lab and in human subjects. It speaks to the power of research: if this trial is successful, we may finally deliver an accessible treatment that can dramatically improve #lymphedema quality-of-life.

Researchers at Stanford University begin drug trial for #lymphedema: "If successful, we may finally deliver an accessible trtmnt that can dramatically improve quality-of-life for the millions who currently live w/ #lymphedema," says Stan Rockson. einnews.com/pr_news/586707… via EIN Presswire

Fantastic news re potential #lymphoedema drug from Stanford Medicine Stan Rockson LE&RN BLS

Please attend this important symposium. You can register here: lymphaticnetwork.org/virtual-lympha… #lymphedema #lymphaticdisease #stanfordmedicine

I'm so honored to serve as the keynote speaker for this NIH-sponsored virtual conference on #lymphatics. Register here: niddk.nih.gov/news/meetings-…

Presenting patient and clinical perspective is a great approach- delighted to be involved LE&RN and introduce Prof. Stanley Rockson Stan Rockson BLS #lymphoedema

Yasuko Iwakiri xiaolei liu Padera Lab Rafa Czepielewski @CastorenaLab Susan Quaggin Nils Gehlenborg Delighted to see finally happening. with speakers such as Stan Rockson and Dr. Mike Davis, phenomenal!

Our paper - in collaboration with Professor Gianesini's laboratory and team - on the identification of the glycocalyx in the human #lymphatic vasculature is available on ResearchGate: researchgate.net/publication/36…

#OriginalResearch: Abnormal sphingosine-1-phosphate (S1P) signaling in lymphatic endothelial cells mediates pathogenic T cell activation, vascular insufficiency and lymphatic dysfunction Stan Rockson Mark Nicolls, MD ahajournals.org/doi/10.1161/CI…

FINDING A DRUG FOR HUMAN LYMPHEDEMA: From Bedside to Bench to Bedside - a fantastic session from Professor Stanley Rockson. Thank you to Stanley for travelling from the States to deliver such great sessions. #BLS2023

It was such a pleasure to have Prof Rockson Stanford Medicine LE&RN as keynote speaker at #BLS2023 conference - inspiring as always! BLS Stan Rockson

Pleased to see our latest paper, "The Role of Inflammation in Lymphedema: A Narrative Review of Pathogenesis and Opportunities for Therapeutic Intervention", published in the International Journal of Molecular Science. Stan Rockson mdpi.com/2736130

NHLBI helps launch the first NIH National Commission on Lymphatic Diseases! nhlbi.nih.gov/news/2024/nhlb…